San Mateo, CA, United States of America

Patrick Andre

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 132(Granted Patents)


Location History:

  • San Mateo, CA (US) (2005 - 2023)
  • Short Hills, NJ (US) (2020 - 2023)

Company Filing History:


Years Active: 2005-2024

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Patrick Andre**

Introduction

Patrick Andre, a notable inventor located in San Mateo, California, has made significant contributions to the field of biopharmaceuticals. With a total of 15 patents to his name, he has been at the forefront of developing innovations that aim to enhance medical treatments and patient safety.

Latest Patents

Among his latest inventions, Patrick has focused on creating antidotes for factor Xa inhibitors. These innovative antidotes are protein derivatives designed to bind to factor Xa inhibitors, effectively neutralizing them without forming part of the prothrombinase complex. Remarkably, these derivatives possess minimal or reduced intrinsic coagulant activity, showcasing their potential utility in clinical settings. The methods disclosed in his patents target stopping or preventing bleeding in patients undergoing anticoagulant therapy with a factor Xa inhibitor, highlighting the importance of his work in improving patient care.

Career Highlights

Throughout his career, Patrick has contributed to several prestigious companies, including Portola Pharmaceuticals, Inc. and Millennium Pharmaceuticals Limited. His roles in these organizations have allowed him to push the boundaries of innovation in the pharmaceutical industry, significantly impacting the development of new therapeutic solutions.

Collaborations

Patrick has worked alongside esteemed colleagues, including David R. Phillips and Uma Sinha, fostering a collaborative environment that encourages the exchange of ideas and accelerates the development of groundbreaking inventions. Their combined efforts reflect a commitment to advancing medical science and improving healthcare outcomes.

Conclusion

Patrick Andre continues to stand out as a prominent inventor in the biopharmaceutical domain. His innovative work on antidotes for factor Xa inhibitors underscores his dedication to enhancing patient safety and treatment efficacy. As he further develops his inventions, the medical community eagerly anticipates the potential benefits his research will bring.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…